Bimmer Claessen retweeted
Proud to have presented the #OPTICA study at #TCT2022. Directly omitting aspirin after successful PCI for ACS is feasible, but RCTs will ultimately need to confirm the efficacy and safety of this novel strategy.🫀#CardioTwitter @TCTConference @BimmerClaessen @yappelman
Bimmer Claessen retweeted
Hot off the Press. Grateful to my mentors and team. Special thanks to @georgedangas Meta-Analysis Comparing Fractional Flow Reserve and Angiography-Guided... sciencedirect.com/science/ar… @FBeerkens @BimmerClaessen @BoopathyCardio @vpasceri @pelliccia_f @ToshikiKuno #cardiotwitter
Thanks to JACC: Asia for the opportunity to co-author this editorial on residual inflammatory risk and PCI with our star fellow Anna van Veelen.
authors.elsevier.com/sd/arti…
Great original research by Jong-Hwa Ahn et al.!
5
Bimmer Claessen retweeted
#RCM - Vol. 23 No. 1
🩸Review
Identification and treatment of the vulnerable coronary plaque
#VulnerablePlaque #Atherosclerosis #AcuteCoronarySyndrome #IntracoronaryImaging
#Non_invasive_imaging
@NielsvdSangen @BimmerClaessen
Fulltext:
imrpress.com/journal/RCM/23/…
Bimmer Claessen retweeted
More on de-escalation antiplatelet therapy following #PCI. Does the Chinese population respond differently? TWILIGHT China substudy #AHAJournals @BimmerClaessen @DJC795 @CMichaelGibson @samtori @gabrielsteg ahajournals.org/doi/10.1161/…
Hot off the press: everything you always wanted to know about “Identification and Treatment of the Vulnerable Plaque”! @RCMjournal tinyurl.com/2v325xya @NielsvdSangen
Bimmer Claessen retweeted
An honor to be part of the organizing committee of the @PCRonline São Paulo Hub. For the first time this important meeting will be broadcasted Live from London to São Paulo @escardio @EuroInterventio @PhilGenereuxMD @BimmerClaessen @georgedangas @Drroxmehran @SVRaoMD @DLBHATTMD
Bimmer Claessen retweeted
In a new Review, @FBeerkens @BimmerClaessen @derrickytam @Drroxmehran et al. discuss contemporary CABG surgery and subsequent percutaneous revascularization rdcu.be/cy0Q0
Bimmer Claessen retweeted
Review of design features and outcomes of various #TAVR devices: There is insufficient evidence to claim superiority of one over another. Still, patient- and anatomy-related factors may favor a specific TAVR device ja.ma/2XJpK7X @BimmerClaessen @GilbertTangMD
Bimmer Claessen retweeted
Updated meta-analysis of 31 trials (n=30,096):
#RadialFirst a/w less bleeding, vascular complications, & mortality than femoral access for coronary angio & PCI.
onlinelibrary.wiley.com/doi/…
@MountSinaiHeart
Follow @CCIJournal, facebook.com/CCIJournal
Official Journal of @SCAI
Bimmer Claessen retweeted
Find out about present and future of best practices regarding evidence-based lipid management after ACS! ow.ly/aXXr50COpny @bimmerclaessen, @Drroxmehran, @ActionCoeur, @MountSinaiHeart #AHAJournals
Just out: "Considerations for Optimal Device Selection in TAVR" Thanks to: @SaminKSharma @GilbertTangMD & dr Annapoorna Kini! ja.ma/3hgrrRK via @JAMACardio part of @JAMANetwork






















